Publication | Closed Access
A New Model for Pricing Drugs of Uncertain Efficacy
19
Citations
0
References
2018
Year
Unknown Venue
Preclinical TherapeuticsPharmacotherapyHealth Care FinanceHarm ReductionExperimental EconomicsMajor RewardsDrug MonitoringDecision TheoryHealth SciencesHealth PolicyNew DrugsPharmacoeconomicsCost EffectivenessHealthcare ValuePharmacologyHealth EconomicsUncertain EfficacyDrug TrialMedicineInnovative Pricing Model
Are we paying too much for new drugs before we know how well they work? This innovative pricing model proposes postponing major rewards until efficacy is established — which could help both patient...